Whitepaper: Neurodegeneration therapeutics discovery

Advance your neurodegeneration research with our broad antibody portfolio, ready-to-use ELISA, and cellular kits to develop new efficacious therapies.

CST application and therapeutic domain experts keep up with the latest research and new neurodegenerative disease treatment approaches to develop a broad portfolio of antibodies, ready-to-use kits, and custom services that could lead to new, more efficacious therapies. Download the Neurodegeneration Therapeutics Discovery brochure and learn about:

  • Solutions for assay development
  • Solutions across the drug development continuum
  • Cellular targets in therapeutic development
  • Cell characterisation markers.